AllPeptides.eu - Advanced Peptide Research
    Back to matrix
    Neuro

    PT-141 (Bremelanotide)

    None of the 30 tracked EU+ jurisdictions lists PT-141 (Bremelanotide) as authorised. This page summarises approval status, brands, shortages and recent regulatory changes by country.

    Protocol detail references

    Related regulatory compounds

    Country-by-country approval and availability

    30 EU+ jurisdictions covered.

    🇩🇪
    Germany

    Strict customs enforcement. No domestic authorisation.

    Research only
    France

    Strict customs enforcement. No domestic authorisation.

    Research only
    🇮🇹
    Italy

    Strict customs enforcement. No domestic authorisation.

    Research only
    🇪🇸
    Spain

    No domestic authorisation — research use only.

    Research only
    🇳🇱
    Netherlands

    No domestic authorisation — research use only.

    Research only
    🇬🇷
    Greece

    No domestic authorisation — research use only.

    Research only
    🇸🇪
    Sweden

    Strict customs enforcement. No domestic authorisation.

    Research only
    🇩🇰
    Denmark

    Strict customs enforcement. No domestic authorisation.

    Research only
    🇫🇮
    Finland

    No domestic authorisation — research use only.

    Research only
    🇦🇹
    Austria

    No domestic authorisation — research use only.

    Research only
    🇧🇪
    Belgium

    No domestic authorisation — research use only.

    Research only
    🇱🇺
    Luxembourg

    No domestic authorisation — research use only.

    Research only
    🇵🇹
    Portugal

    No domestic authorisation — research use only.

    Research only
    🇮🇪
    Ireland

    No domestic authorisation — research use only.

    Research only
    🇵🇱
    Poland

    No domestic authorisation — research use only.

    Research only
    🇨🇿
    Czech Republic

    No domestic authorisation — research use only.

    Research only
    🇸🇰
    Slovakia

    No domestic authorisation — research use only.

    Research only
    🇭🇺
    Hungary

    No domestic authorisation — research use only.

    Research only
    🇸🇮
    Slovenia

    No domestic authorisation — research use only.

    Research only
    🇭🇷
    Croatia

    No domestic authorisation — research use only.

    Research only
    🇪🇪
    Estonia

    No domestic authorisation — research use only.

    Research only
    🇱🇻
    Latvia

    No domestic authorisation — research use only.

    Research only
    🇱🇹
    Lithuania

    No domestic authorisation — research use only.

    Research only
    🇷🇴
    Romania

    No domestic authorisation — research use only.

    Research only
    🇧🇬
    Bulgaria

    No domestic authorisation — research use only.

    Research only
    🇨🇾
    Cyprus

    No domestic authorisation — research use only.

    Research only
    🇲🇹
    Malta

    No domestic authorisation — research use only.

    Research only
    🇬🇧
    United Kingdom

    No domestic authorisation — research use only.

    Research only
    🇨🇭
    Switzerland

    Strict customs enforcement. No domestic authorisation.

    Research only
    🇳🇴
    Norway

    Strict customs enforcement. No domestic authorisation.

    Research only

    Educational Navigator

    Educational reading navigator

    Find where to start in research peptide science through evidence, safety context and regulatory awareness.

    Covers

    Evidence levelsSafety contextRegulatory overviewLiterature readingResearch methodEducational reports
    5 min readEvidence-firstOpen access
    Open evidence framework

    New knowledge, new tools and selected updates from AllPeptides.eu